Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy. - Wikidata - thesis-toulmin - TriplyDB

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

http://www.wikidata.org/entity/Q34995286

about

A CD8 T-cell epitope variant enhances immune targeting to a recombinant picornavirus vaccine antigen.Picornavirus infection leading to immunosuppression.Contrasting roles for CD4 vs. CD8 T-cells in a murine model of virally induced "T1 black hole" formation.An elite controller of picornavirus infection targets an epitope that is resistant to immune escape Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma Enhancing the Tumor Selectivity of a Picornavirus Virotherapy Promotes Tumor Regression and the Accumulation of Infiltrating CD8+ T Cells.The epitope integration site for vaccine antigens determines virus control while maintaining efficacy in an engineered cancer vaccine.Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption.Brain atrophy in picornavirus-infected FVB mice is dependent on the H-2Db class I molecule.Superior isolation of antigen-specific brain infiltrating T cells using manual homogenization technique.Non-equivalent antigen presenting capabilities of dendritic cells and macrophages in generating brain-infiltrating CD8 + T cell responses.

P2860

Q34113916-BE672AF0-89C4-4C25-BFF8-D84C130EB5E5 Q34149230-BB118FA2-8DAD-4BA5-A23C-DBE7FD15BE75 Q34163547-0C85222F-29DE-4E73-8276-EDB624762C21 Q35142111-69C0EC15-B8C5-4D60-9B7D-B5407A1E690D Q35561280-86473F65-8BE3-4C97-9FED-D40963324421 Q36112877-A7D308F9-D40B-43C7-8FC8-33AD2834B547 Q36665114-8E30B1FE-BF0A-472E-BCAA-BD763E0D7FD1 Q36883892-F980B402-1883-4F3A-A132-CA7296CAFEAC Q37220962-E9D59661-9932-49E8-B078-FA5000478504 Q40336663-564B69FA-5EF4-4631-B3B6-2B9D3C0EDE08 Q40541873-9D188FB4-F6F5-49A7-B2DF-246F30127039 Q50055506-BEE8C280-283C-46EF-8BB5-B5B80250EBC3

P2860

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

http://www.wikidata.org/entity/Q34995286

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

@ast

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

@en

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

@nl

type

label

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

@ast

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

@en

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

@nl

prefLabel

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

@ast

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

@en

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

@nl

P1433

Q34995286-8B03BCEF-69BC-438F-BDE4-DB06258C248C

P1476

Q34995286-7492B2B2-5D4E-4955-A87B-62B42B90AB42

P2093

Q34995286-46D287F1-967A-466D-AED8-FCF62E27D4FF

Q34995286-558B0FDD-AF95-45AA-B9A9-4C418467D494

Q34995286-5E8D2E13-EF26-4B45-B57F-865CCD4F6245

Q34995286-6072C192-B365-4A5A-981A-71ABDDC60191

Q34995286-9B358BA7-F3C9-46B0-A027-932252FE2AC0

Q34995286-B896D486-A852-445F-B2A0-F9C4B52A97F3

Q34995286-CB946683-989C-47B1-9C32-D7382A564191

P2860

Q34995286-08A03F00-D1EA-4CB4-9756-FDBE07DCA446

Q34995286-14C7D75A-BDA8-4859-BF79-AD0869FD0136

Q34995286-15EE5A18-CDFB-4C65-B2F3-519231DEF6C7

Q34995286-3110DC4E-B718-4477-A2EC-0F68E82A6669

Q34995286-3204A83F-7E4C-4BCC-BB9E-40D3E2F1643F

Q34995286-44518DBA-B27C-4245-B31A-C6661C76194C

Q34995286-4700AC08-FC52-4918-A8E2-84C87E3DA16A

Q34995286-47C0D8FC-613B-4EED-A224-BEF7C293F629

Q34995286-48D54FFC-B428-4D16-9176-F7E4FCC03C8B

Q34995286-4D3C11D4-85F8-4B02-8EEC-8620DC3D1FD8

P304

Q34995286-00E70954-B313-4209-A6AF-101FD40DB70F

P31

Q34995286-F2371D98-C7CF-4F6D-BF95-F69BFC6CD29D

P356

Q34995286-44ED3EFB-1B0E-4FA1-BD4E-C6B621FD3526

P407

Q34995286-7744BABA-2379-44CD-8715-D2DA4419C4F2

P433

Q34995286-5FE62966-B4F1-4EB5-A152-9509EE8D169C

P478

Q34995286-17B75A86-E416-44F7-96F1-11D914F2FD92

P50

Q34995286-0B501041-AEC3-4941-8C77-D77F36A29ADC

Q34995286-6712A4D4-12F3-4CB8-A4D4-E1314782A0DA

P577

Q34995286-EAECB06D-D515-4546-8CB2-C46EEB0E0B94

P5875

Q34995286-A83AAF1A-4C28-4789-BC52-C00B9F373DEA

P698

Q34995286-2F0F5C4E-4C33-4801-8EA8-C184A4192219

P921

Q34995286-2FFC17AF-A8E5-42D9-BF1C-A8002170F9A4

P932

Q34995286-2F236CCF-7684-4765-B14F-2514195B6501

P356

JOURNAL.PONE.0020217

P1433

P1476

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

@en

P2093

Kathleen S Allen

http://www.w3.org/2001/XMLSchema#string

Larry R Pease

http://www.w3.org/2001/XMLSchema#string

Megan A Girtman

http://www.w3.org/2001/XMLSchema#string

Michael J Hansen

http://www.w3.org/2001/XMLSchema#string

Michael P Bell

http://www.w3.org/2001/XMLSchema#string

Yanice V Mendez-Fernandez

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Mitsunaga

http://www.w3.org/2001/XMLSchema#string

P2860

Saffold virus, a human Theiler's-like cardiovirus, is ubiquitous and causes infection early in life

Discovery of a novel human picornavirus in a stool sample from a pediatric patient presenting with fever of unknown origin

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation

Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue

CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues

Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28.

Theiler's virus infection of perforin-deficient mice.

The leader polypeptide of Theiler's murine encephalomyelitis virus is required for the assembly of virions in mouse L cells.

The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production.

P304

e20217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0020217

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Moses Rodriguez

P577

2011-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51177523

http://www.w3.org/2001/XMLSchema#string

P698

21625449

http://www.w3.org/2001/XMLSchema#string

P921

P932

3098865

http://www.w3.org/2001/XMLSchema#string